Company / Free Cash Flow per Share
Integra Lifesciences Holdings Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.39
FY2025
5-year range
-$0.39 / $3.06
FY2021-FY2025
Trend
-229.3%
vs FY2024
Sector context
#128 of 148
Health Care
What the data says
Free Cash Flow per Share changed -229% YoY in FY2025, a notable deviation from the 9-year average annual change of -21%.
Based on SEC 10-K filings.
-0.39 in FY2025.
Declined from $0.86 to $-0.39 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 148This company -$0.39 Sector average $5.04
▼
-107.7% below sector average
Key checks
Key Insights
- Integra Lifesciences Holdings's free cash flow per share has declined for 4 consecutive years.
- In FY2025, free cash flow per share decreased 229.3% year-over-year.
- Ranks #128 out of 148 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.39 | -229.3% |
| FY2024 | $0.30 | -65.0% |
| FY2023 | $0.86 | -67.2% |
| FY2022 | $2.61 | -14.7% |
| FY2021 | $3.06 | +55.7% |
| FY2020 | $1.96 | -4.0% |
| FY2019 | $2.05 | +32.9% |
| FY2018 | $1.54 | +53.8% |
| FY2017 | $1.00 | +45.9% |
| FY2016 | $0.69 | -72.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026